Urinary Tract Cancer
📧 Sign up to get email alerts when something new happens for Urinary Tract Cancer.
Sign up freeTop drugs studied for this disease
-
CLINICAL_TRIALS trial_result · 2026-04-16Clinical Trial Update: Pembrolizumab With Intratumoral Injection of Clostridium Novyi-NT [Phase 1]
Phase 1 clinical trial evaluating pembrolizumab in combination with intratumoral injection of Clostridium novyi-NT across multiple cancer ty…
-
CLINICAL_TRIALS research · 2026-04-08Clinical Trial Update: A Study of BL-M07D1 in Patients With a Variety of Solid Tumors Including Locally Advanced or Metastatic HER2-positive/Low-expressing Urinary and Gastrointestinal Tumors [Phase 1, Phase 2]
An ongoing Phase 1/2 study (BL-M07D1) in patients with solid tumors, including HER2-positive/low-expressing urinary and digestive tract tumo…
-
CLINICAL_TRIALS research · 2026-04-02Clinical Trial Update: Care of the Urothelial Cancer Patient and Prospective Procurement of Urothelial Cancer Tissue
This ClinicalTrials.gov entry describes the NCI-sponsored study NCT02379429, a trial focusing on care of urothelial cancer patients and pros…
-
CLINICAL_TRIALS research · 2026-03-04Clinical Trial Update: Trial of Ado-Trastuzumab Emtansine for Patients With HER2 Amplified or Mutant Cancers [Phase 2]
Clinical trial update on a Phase 2 study of ado-trastuzumab emtansine for HER2-amplified or HER2-mutant cancers; the trial is currently acti…
-
CLINICAL_TRIALS trial_result · 2025-12-24Clinical Trial Update: Diagnostic Relevance of Laser Confocal Microscopy for the Screening of Upper Urinary Tract Tumors [NA]
A completed clinical trial from Lille Catholic University evaluated the diagnostic relevance of laser confocal microscopy for screening uppe…
- Want full summaries, importance scores, and drug timelines? Upgrade to Plus or Pro.
-
CLINICAL_TRIALS research · 2025-09-26Clinical Trial Update: A Study of BL-B01D1 in Patients With Locally Advanced or Metastatic Urological Tumors and Other Solid Tumors [Phase 1]
Phase 1 clinical trial update for BL-B01D1 in Locally Advanced or Metastatic Urinary Tract Cancers and Other Solid Tumors; the study is curr…
-
CLINICAL_TRIALS trial_result · 2024-11-13Clinical Trial Update: Basket Study of Tucatinib and Trastuzumab in Solid Tumors With HER2 Alterations [Phase 2]
Phase 2 basket trial evaluating tucatinib in combination with trastuzumab across HER2-altered solid tumors, with results posted for several …
-
CLINICAL_TRIALS research · 2024-07-08Clinical Trial Update: The Research Value of Multi-omics and Multi-modal Information in the Diagnosis and Treatment of Urinary System Tumors
This clinical trial investigates the value of combining multi-omics and multi-modal information to improve diagnosis and treatment of urinar…
-
CLINICAL_TRIALS trial_result · 2024-05-23Clinical Trial Update: A Study of Cadonilimab（AK104）Combined With Standard Treatment for Function Preservation in Urinary System Tumors [Phase 2]
Phase 2 study evaluating Cadonilimab (AK104) in combination with standard treatment for function preservation in urinary tract cancers; the …
-
CLINICAL_TRIALS trial_result · 2024-04-04Clinical Trial Update: A Study of Atezolizumab in Locally Advanced or Metastatic Urothelial or Non-Urothelial Carcinoma of the Urinary Tract [Phase 3]
Phase 3 trial of atezolizumab in locally advanced or metastatic urothelial or non-urothelial carcinoma of the urinary tract has completed wi…
-
CLINICAL_TRIALS trial_result · 2022-10-03Clinical Trial Update: Atezolizumab Immunotherapy, in Immunotherapy Naive Patients With Urinary Tract Squamous Cell Carcinoma (UTSCC). [Phase 2]
Phase 2 clinical trial update for atezolizumab in immunotherapy-naive patients with urinary tract squamous cell carcinoma (UTSCC).
-
CLINICAL_TRIALS trial_result · 2018-06-06Clinical Trial Update: CLE Characteristics of Upper Urinary Tract Urothelial Carcinoma
The clinical trial investigating CLE characteristics of upper urinary tract urothelial carcinoma has completed.
-
CLINICAL_TRIALS withdrawal · 2017-06-26Clinical Trial Update: Lenvatinib and Capecitabine in Patients With Advanced Malignancies [Phase 1]
A Phase 1 study of lenvatinib in combination with capecitabine for patients with advanced cancers has been withdrawn.
-
CLINICAL_TRIALS withdrawal · 2016-07-12Clinical Trial Update: Docetaxel and St. John's Wort in Treating Patients With Solid Tumors That Cannot Be Removed By Surgery [Phase 3]
A Phase 3 trial evaluating docetaxel in combination with St. John's Wort for solid tumors that cannot be removed surgically has been withdra…